MarketBeat
22 Nov 2026, 04:12 UTC · 1h ago
Quest Diagnostics Sees Hospital Deal Growth as 2027 Medicare Cuts Loom
Impact · against what's priced in
The news is largely noise for AAPL given the immaterial scale of the partnership, while DGX faces a mild headwind from upcoming Medicare cuts that offsets the positive momentum from hospital partnerships.
- AAPL+0.00
Doesn't touch the price's assumptions
- The price assumes
Services compounding at 13.5% on a 26% revenue share
The partnership with Quest allows consumers to order biomarkers in the app, but since Quest's entire consumer business represents less than 3% of its own revenue, the contribution to Apple's services growth is negligible.





